NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Gaudium IVF IPO Receives Strong Subscription

On February 20, the second day of subscription for the initial public offering (IPO) of Gaudium IVF and Women Health saw strong demand, with the issue receiving 1.67 times subscription until 11:15 am. The company's IPO received bids for 2.44 crore shares against the 1.46 crore shares on offer, as per the NSE data.

Subscription Details

  • Retail individual investors subscribed 2.41 times, while non-institutional investors received 2.18 times subscription.
  • On the first day of subscription, the Rs 165-crore issue received 88 percent subscription.
  • The issue raised Rs 49.5 crore from anchor investors earlier.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

IPO Details

  • The IPO will conclude on February 24.
  • Gaudium IVF becomes the first company in the fertility care sector to tap the public markets.
  • The company fixed the price band at Rs 75-79 per share, valuing the company at Rs 575 crore.

Grey Market Activity

  • Platforms tracking grey market activities indicate that the shares of Gaudium IVF are commanding a GMP of up to 11 percent in the unofficial market.
  • Investorgain quoted a GMP of Rs 7.5 for the shares of the company, indicating a listing gain of 9.49 percent.
  • IPO Watch quoted a GMP of 10.76 percent.

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Proceeds and Listing

  • Proceeds from the fresh issue are intended to establish 19 new IVF centres across India, along with payment of debt and for general corporate purposes.
  • Gaudium IVF IPO allotment is expected by February 25, with share market listing scheduled on February 27.

Investor Takeaway

Investors should be aware of the strong demand for Gaudium IVF's IPO, which may indicate a positive market reception.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.